Search Results 111-120 of 17142 for egfr
EGFR promotes cancer growth. Cetuximab (Erbitux) and panitumumab (Vectibix) target EGFR. These medicines are used to treat people with genetic changes known as ...
... EGFR mutant population. Patients will be enrolled over a three year period across approximately 25 geographically diverse academic as well as community ...
... (eGFR ≥ 60ml/min). Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies. Scottsdale/Phoenix, Ariz. The ...
Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...
Erlotinib (Tarceva) is a human EGFR type 1 tyrosine kinase inhibitor and offers greater survival benefit to EGFR positive patients. This study will assist ...
... receptor (EGFR) status of adenocarcinoma of the lung, allowing for better selection of subjects for EGFR-targeted therapy without necessitating biopsy.
Jiang H, Nace R, Ferguson C, Zhang L, Peng KW, Russell SJ. Oncolytic cytomegaloviruses expressing EGFR-retargeted fusogenic glycoprotein complex and drug- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.